A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

(2015) Julie Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

(2014) A. J. M. Nieuweboer et al.   CANCER RESEARCH

Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

(2013) A. A. M. van der Veldt et al.   CLINICAL CANCER RESEARCH

Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP

(2012) Hiroyuki Kusuhara et al.   BRITISH JOURNAL OF PHARMACOLOGY

Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study

(2011) K Maeda et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects

(2011) H Kusuhara et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose

(2011) Ichiro Ieiri et al.   Pharmacogenetics and Genomics

Impact of microdosing clinical study — Why necessary and how useful?

(2010) Yuichi Sugiyama et al.   ADVANCED DRUG DELIVERY REVIEWS

Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice

(2009) Hironobu Minami et al.   CANCER SCIENCE

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

(2008) Kazuma Kiyotani et al.   CANCER SCIENCE